Gland Pharma fundamental analysis
GLAND
1638
15.50 (-0.94%)Last updated on 29 Dec, 2025 | 11:20 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Gland Pharma Fundamentals
P/E Ratio
34.38
P/B Ratio
2.84
Div. Yield
1.09
Sector P/E
70.63
Sector P/B
1
Sec. Div. Yield
0.56
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 34.38, compared to the sector average of 70.63. Its P/B Ratio stands at 2.84, while the sector’s is 1. In terms of returns, the stock offers a Dividend Yield of 1.09%, which is than the sector’s 0.56%.
Gland Pharma Score Card
Price
Attractive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
